Is Flow Cytometry a Useful Test? R epresenting a busy flow cytometry laboratory with an annual workload of approximately 1400 acute leukemia and malignant lymphoma cases, we read the article by Naughton et al. 1 with considerable interest. The authors concluded that "flow cytometry of bone marrow as
Telomerase activity in precancerous hepatic nodules
โ Scribed by Prodromos Hytiroglou; Vassiliki Kotoula; Swan N. Thung; Maria Tsokos; M. Isabel Fiel; Constantine S. Papadimitriou
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 360 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
Recent studies have demonstrated that telomerase, a reverse transcriptase linked to cellular "immortalization," is activated in a variety of malignant human tumors. this study was conducted to determine whether telomerase activity represents a marker of malignant transformation in precancerous (dysplastic) nodules arising in patients with cirrhosis.
Methods:
Telomerase activity was evaluated in frozen tissue samples of 14 cirrhotic liver specimens and 30 large nodular lesions contained therein, including 13 large regenerative nodules/low grade dysplastic nodules, 10 high grade dysplastic nodules, and 7 hepatocellular carcinomas (hccs). a modified telomeric repeat amplification protocol was used.
Results:
There was a clear-cut difference in telomerase activity levels between hcc (positive or strongly positive) and cirrhotic liver samples (weakly positive or negative). the majority of large noncancerous nodules (86%) exhibited telomerase activity levels similar to hccs. however, such activity was not limited to dysplastic lesions but also was detected in some large regenerative nodules.
Conclusions:
These findings suggest that telomerase activation is an early event in large nodule formation in cirrhosis, which may facilitate the action of other factors in the process of carcinogenesis. telomerase activity in large hepatic nodules is not always indicative of malignant transformation.
๐ SIMILAR VOLUMES
## Background: Telomeric repeat amplification protocol using internal telomerase assay standard (itas) (conventional trap) has detected telomerase activity in various malignant tumors. with conventional trap, it is difficult to differentiate quantitatively low levels of telomerase activity between
Background and Objectives: Telomerase is a ribonucleoprotein that synthesizes telomeric DNA. Immortalized and carcinoma cells show no loss of telomere length during cell division. Telomerase activity has been demonstrated in carcinomas of various organs, but not in nonneoplastic tissues. In patients
## Background: Shortening of telomeres occurs with each cell division and eventually results in cell death. the activity of telomerase, an enzyme that catalyzes telomere elongation, has been detected in germ cell lines and cancer cells, and has been detected in immortal cell lines but not in normal
Telomerase activity has been detected in germ cells as well as in the developing embryo. Activity is no longer detectable in most somatic cells of the neonate, although low levels of activity persist in regenerative tissues. Telomerase has been found to be reactivated or up-regulated in the majority
## BACKGROUND. Telomerase activity has been observed in 80 -90% of carcinomas derived from various organs. However, to the authors' knowledge this report is the first assessment of telomerase activity in gastrointestinal stromal tumors (GISTs). ## METHODS. Telomerase activity was analyzed by th